Navigation Links
World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children
Date:8/23/2010

ines, including Prevnar. Hypersensitivity to any vaccine component, including diphtheria toxoid, is a contraindication to its use. Prevnar does not protect 100 percent of children vaccinated. Immunization with Prevnar does not substitute for routine diphtheria immunization.

Pfizer Inc: Working together for a healthier world™

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at www.pfizer.com.

DISCLOSURE NOTICE: The information contained in this release is as of August 23, 2010. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

This release contains forward-looking information that involves substantial risks and uncertainties regarding Prevenar 13 for use in infants and young children in the various countries in which the Company's regulatory applicat
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. US WorldMeds Acquires Solstice Neurosciences
2. The Starkey Hearing Foundation 10th Anniversary So the World May Hear Gala Week
3. Worlds Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients
4. Partnership Brings Breast Image Documentation Technology to Women Around the World
5. US WorldMeds Announces the Launch of Revonto™ (dantrolene sodium for injection)
6. The SCOOTER Store Donates Power Mobility Scooter to Worlds Tallest Teenager
7. NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
8. PartsSource Wins 2010 World Class Customer Service Award
9. Frankfurt To Host Worlds Largest Pharmaceutical Services Events In 2011
10. World Diet Food and Confectionery Market (2010 -2015): MarketsandMarkets
11. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... -- Semler Scientific, Inc. (Nasdaq: SMLR ), an ... markets products that assist healthcare providers in monitoring patients ... the first quarter ended March 31, 2015. ... continued progress with year over year growth of 44% ... said Doug Murphy-Chutorian , M.D., chief executive officer ...
(Date:5/1/2015)... May 1, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... E. Morris , chief financial officer  will be participating ... are as follows: Mizuho Third Annual Healthcare ... Omni Berkshire Place, New York ...
(Date:5/1/2015)... YORK , May 1, 2015  Shares of ... 70% of their value yesterday following the results of ... glaucoma therapy, Rhopressa.  Despite the trial failing to meet ... that positive results may come from future studies. ... brief company overview, current pipeline, financial review, analyst summary, ...
Breaking Medicine Technology:Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... DIEGO, Oct. 20 Aethlon Medical, Inc. (OTC Bulletin ... the Aethlon Hemopurifier® is effective in capturing the current ... Hemopurifier® is the first-in-class medical device able to selectively ... During invitro studies, the Hemopurifier® removed ...
... , WALTHAM, Mass., Oct. 20 Logical Therapeutics, Inc. ... treat medical conditions associated with inflammation, has been selected ... the gastrointestinal (GI) safety of its lead product LT-NS001, ... Annual Scientific Meeting on October 27, 2009. , ...
Cached Medicine Technology:Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus 2Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus 3Logical Therapeutics to Present Data on LT-NS001 at American College of Gastroenterology Annual Meeting 2
(Date:5/3/2015)... May 03, 2015 AvePoint, ... across platforms and devices, today announced it is ... Privacy Professionals (IAPP) Asia Privacy Forum, taking place ... Throughout the event, AvePoint will showcase its compliance, ... cloud platforms. , Visit AvePoint for New Solutions ...
(Date:5/3/2015)... 2015 Barbara Crone has joined Women’s Excellence ... being of the men, women and families who seek her care, ... care for families in the home. , “When ... wondering if I could complete their care with the delivery of ... my mentor Nurse Midwife, I knew it was time for me ...
(Date:5/3/2015)... Metamora, Michigan (PRWEB) May 03, 2015 ... mark on their Facebook page. , Their ... on the many services the Practice has, it’s multiple ... events. , Women’s Excellence has a very strong social ... Pinterest, Instagram and You Tube. , Women’s Excellence ...
(Date:5/3/2015)... Association 2015 Meeting & Tradeshow (PRWEB) May 03, ... full-service telemedicine and mobile health services provider today ... health services for chronic disease management, in the ... remote patient monitoring of a variety of chronic ... diabetes, COPD, hypertension and other chronic illnesses. , ...
(Date:5/3/2015)... Leading international program provider, Child ... awarding the 2015 Harris Wofford Global Service Fellowships. CFHI ... the deserving recipients of the award named after former ... Wofford. The two recipients were chosen for their strong ... , CFHI is one of seven organizations participating ...
Breaking Medicine News(10 mins):Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 4Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 3Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3
... At ... about profitable new strategies, especially in the areas of financing and operations, that they can ... ... sponsored by Horst Construction will be held from 8:30 a.m. to 2 p.m. on Thursday, ...
... 2010 Of the 200,000 men newly diagnosed with ... one-third will undergo surgical treatment. Although open radical prostatectomy ... prostatectomy (LRP) with or without robotic assistance is becoming ... today in The Journal of Urology , researchers ...
... ATLANTA--A new study has found that many male cancer ... radiation therapy have an impaired quality of life and ... , a peer-reviewed journal of the American Cancer Society, ... testosterone deficiency may benefit from testosterone replacement therapy. ...
... are being denied access to adequate pain relief because ... opioid-based drugs such as morphine. Authors ... pain-killing drugs in this way is a breach of ... an ethical and public health imperative to address these ...
... ... ... ... ...
... ... service, Thibadeau Mortuary opens it newest location in beautiful Olde Towne Gaithersburg Maryland. ... serve today,s creative and multicultural community. , ... Gaithersburg, MD (PRWEB) February 21, 2010 -- A new, affordable ...
Cached Medicine News:Health News:Register Online for this Year's Horst Senior Living Conference on April 8 Featuring Keynote Speaker and Senior Housing Expert Jim Moore 2Health News:Few differences in outcomes between open and laparoscopic prostate surgery 2Health News:Inadequate access to opioid-based pain relief is a human rights issue for cancer patients 2Health News:Inadequate access to opioid-based pain relief is a human rights issue for cancer patients 3Health News:Inadequate access to opioid-based pain relief is a human rights issue for cancer patients 4Health News:Live with Regis and Kelly Reveal A REVOLUTIONARY Pain Relief Method 2Health News:Live with Regis and Kelly Reveal A REVOLUTIONARY Pain Relief Method 3Health News:Olde Towne Gaithersburg Welcomes Thibadeau Mortuary - A Lower-Cost Alternative In Funeral and Cremation Service 2Health News:Olde Towne Gaithersburg Welcomes Thibadeau Mortuary - A Lower-Cost Alternative In Funeral and Cremation Service 3
For use with catalog #0454....
Immuno-turbidimetric Assay of D-Dimer by STA© Analyzers. Microlatex particles coated with two different mouse monoclonal anti-human D-Dimer antibodies....
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasmawith heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all free...
Antigenic Total Protein S, ELISA Method...
Medicine Products: